| 2023 | DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK Activation
| CANCERS |
| 2022 | Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myeloma | BRITISH JOURNAL OF HAEMATOLOGY |
| 2022 | Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
| SCIENTIFIC REPORTS |
| 2022 | Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study
| CANCER RESEARCH AND TREATMENT |
| 2022 | Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients
| JOURNAL OF MOLECULAR DIAGNOSTICS |
| 2021 | Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma | CLINICAL CANCER RESEARCH |
| 2021 | Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
| EXPERIMENTAL HEMATOLOGY & ONCOLOGY |
| 2021 | Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2020 | Immunosuppressive role of CD11b + CD33 + HLA-DR - myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia
| CANCER MEDICINE |
| 2020 | Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma | ANNALS OF HEMATOLOGY |
| 2020 | Renal intravascular large B cell lymphoma: the first case report in Korea and a review of the literature
| JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE |
| 2020 | Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease | ANNALS OF HEMATOLOGY |
| 2020 | ULK1 Inhibition as a Targeted Therapeutic Strategy for FLT3-ITD-mutated Acute Myeloid Leukemia
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
| 2020 | PERK/NRF2 and Autophagy Form a Resistance Mechanism Against G9a Inhibition in Leukemia Stem Cells
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
| 2019 | Early Cytomegalovirus Reactivation and Expansion of CD56brightCD16dim/-DNAM1+ Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute Leukemia | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| 2019 | Induction of apoptosis and differentiation by Na/H exchanger 1 modulation in acute myeloid leukemia cells | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2018 | HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma
| CANCER RESEARCH AND TREATMENT |
| 2017 | Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma | HEMATOLOGICAL ONCOLOGY |
| 2017 | Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma
| ONCOTARGET |
| 2017 | Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience
| BLOOD RESEARCH |
| 2017 | Prognostic significance of interventricular septal thickness in patients with AL amyloidosis | LEUKEMIA RESEARCH |
| 2016 | The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma | BRITISH JOURNAL OF HAEMATOLOGY |
| 2016 | A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma | EUROPEAN JOURNAL OF CANCER |
http://orcid.org/0000-0002-7926-9285
